Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies

R Akbar, H Bashour, P Rawat, PA Robert, E Smorodina… - MAbs, 2022 - Taylor & Francis
Although the therapeutic efficacy and commercial success of monoclonal antibodies (mAbs)
are tremendous, the design and discovery of new candidates remain a time and cost …

Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery

W Wilman, S Wróbel, W Bielska… - Briefings in …, 2022 - academic.oup.com
Antibodies are versatile molecular binders with an established and growing role as
therapeutics. Computational approaches to developing and designing these molecules are …

In silico proof of principle of machine learning-based antibody design at unconstrained scale

R Akbar, PA Robert, CR Weber, M Widrich, R Frank… - MAbs, 2022 - Taylor & Francis
Generative machine learning (ML) has been postulated to become a major driver in the
computational design of antigen-specific monoclonal antibodies (mAb). However, efforts to …

Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics

R Khetan, R Curtis, CM Deane, JT Hadsund, U Kar… - MAbs, 2022 - Taylor & Francis
Therapeutic monoclonal antibodies and their derivatives are key components of clinical
pipelines in the global biopharmaceutical industry. The availability of large datasets of …

Unconstrained generation of synthetic antibody–antigen structures to guide machine learning methodology for antibody specificity prediction

PA Robert, R Akbar, R Frank, M Pavlović… - Nature Computational …, 2022 - nature.com
Abstract Machine learning (ML) is a key technology for accurate prediction of antibody–
antigen binding. Two orthogonal problems hinder the application of ML to antibody …

Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells

D Neumeier, A Yermanos, A Agrafiotis… - Proceedings of the …, 2022 - National Acad Sciences
The capacity of humoral B cell-mediated immunity to effectively respond to and protect
against pathogenic infections is largely driven by the presence of a diverse repertoire of …

[HTML][HTML] SARS-CoV-2 reactive and neutralizing antibodies discovered by single-cell sequencing of plasma cells and mammalian display

RA Ehling, CR Weber, DM Mason, S Friedensohn… - Cell reports, 2022 - cell.com
Characterization of COVID-19 antibodies has largely focused on memory B cells; however, it
is the antibody-secreting plasma cells that are directly responsible for the production of …

Reference-based comparison of adaptive immune receptor repertoires

CR Weber, T Rubio, L Wang, W Zhang, PA Robert… - Cell Reports …, 2022 - cell.com
B and T cell receptor (immune) repertoires can represent an individual's immune history.
While current repertoire analysis methods aim to discriminate between health and disease …

Disease diagnostics using machine learning of immune receptors

ME Zaslavsky, E Craig, JK Michuda, N Sehgal… - Biorxiv, 2022 - biorxiv.org
Clinical diagnoses rely on a wide variety of laboratory tests and imaging studies, interpreted
alongside physical examination findings and the patient's history and symptoms. Currently …

Deep Learning in Therapeutic Antibody Development

JM Shaver, J Smith, T Amimeur - Artificial Intelligence in Drug Design, 2022 - Springer
Deep learning applied to antibody development is in its adolescence. Low data volumes
and biological platform differences make it challenging to develop supervised models that …